Fructosamine measures glucose bound to serum proteins, reflecting average glucose exposure over the past 2-3 weeks, a shorter window than HbA1c's 8-12 weeks. It's useful when faster feedback on glucose control is needed.
Fructosamine serves as an alternative or complement to HbA1c in specific situations: for people with hemoglobin variants that affect HbA1c accuracy, during pregnancy when glucose control changes rapidly, or when tracking the effect of a recent intervention. It's less commonly ordered than HbA1c but valuable when the 3-month HbA1c window is too slow to see change.
Optimal Fructosamine: 190-228 µmol/L.
Typically re-tested every 4 weeks.
Clinicians reach for it when the longer marker may mislead, or when they want feedback sooner. That includes pregnancy, people with anemia or unusual red blood cell turnover, and the weeks after a change in diet, activity or therapy. It is reported in µmol/L and does not require fasting.
Fructosamine is a laboratory measure of glycated serum proteins, the fraction of the proteins circulating in your blood, mostly albumin, that have glucose permanently attached to them.
The attachment happens without any enzyme involved. Glucose in the bloodstream binds to amino groups on proteins, and that unstable first bond rearranges into a stable ketoamine, the structure the assay detects. The more glucose circulating, and the longer it circulates, the more of these glycated proteins accumulate. Most laboratories quantify them with a colourimetric method in alkaline conditions, which is why the result is a total measure of glycated serum protein rather than a count of any single protein.
The timing is what makes the marker distinctive. Red blood cells survive for roughly three months, so the glycated hemoglobin they carry averages glucose across that period. Serum albumin turns over far faster, with a circulating lifespan measured in weeks rather than months. Labs therefore regard fructosamine as an average of the preceding two to three weeks, which shortens the feedback loop considerably.
A closely related test, glycated albumin, measures the same chemistry but limits itself to albumin and expresses the result as a percentage. Research comparing hemoglobin A1c, glycated albumin and glycosylated serum protein in people with aplastic anemia and type 2 diabetes illustrates why more than one glycemic marker is sometimes needed, since conditions affecting red blood cells can pull these measures apart 1.
Related: Fructosamine Test Cost and What Drives the Price
It matters because protein glycation is a readout of how much glucose your tissues have been bathed in recently, and sustained glucose exposure is associated with the vascular, nerve and joint changes that shape long-term health.
Analyses from a large osteoarthritis cohort suggest that glucose homeostasis influences the risk of incident knee osteoarthritis 2, and a related cross-sectional study reported that inflammation and glucose homeostasis were associated with specific structural features in adults who did not yet have knee osteoarthritis 3. Further work from the same cohort indicates that combinations of risk factors can help classify individuals who go on to develop accelerated knee osteoarthritis 4. None of this says a glycation marker causes joint damage, but it places glucose control inside a broader picture than diabetes alone.
Glucose rarely travels by itself either. In type 2 diabetes, lipid biology sits alongside it, and an analysis of the DAIS trial examined fenofibrate, HDL and cardiovascular disease in that population 5. Inflammation is part of the same cluster, and a 30 month randomized placebo-controlled trial of salsalate in overweight people with diabetes risk factors and stable statin-treated cardiovascular disease reported improvements in glycaemia 6, which supports the broader view that inflammatory and glycemic pathways move together. Any prescription therapy of that kind is evaluated by a licensed provider for a specific person.
The practical value of the shorter window is simple. If you change something this month, a two to three week marker can show movement long before a three month marker does.
Most laboratories report a typical adult reference range of 190 to 270 µmol/L, while FitScript's optimal range is narrower at 190 to 228 µmol/L.
| Measure | Range (µmol/L) |
|---|---|
| Typical lab reference range | 190 to 270 |
| FitScript optimal range | 190 to 228 |
These are typical lab reference ranges, and they vary by laboratory, assay method, age and sex. No separate age or sex specific bands are given here, because the available data does not supply them. FitScript's optimal range is an optimization target, not a diagnostic cut-off, and sitting outside it does not establish that anything is wrong.
Two details change how the number should be read. First, the assay reflects total glycated serum protein, so the amount of protein in the sample matters. Low serum albumin pulls the result down and high albumin pushes it up, independent of glucose, which is why some laboratories also report an albumin-corrected value. Second, results from different assay platforms are not always interchangeable, so a trend measured at the same laboratory is more informative than a single value compared against a result from elsewhere.
A result above the laboratory's upper limit usually means average blood glucose ran higher than typical across the preceding two to three weeks, although protein levels and assay interference can contribute.
People with persistently raised glucose often report nothing at all, which is the main argument for testing rather than guessing. When symptoms do appear, the commonly described ones are increased thirst, more frequent urination, fatigue in the hours after meals, blurred vision that fluctuates, slow-healing cuts and recurrent skin or urinary infections.
High serum albumin, including from dehydration at the time of the draw, can also nudge the number upward.
The long-term relevance is cumulative rather than immediate. Years of elevated glucose exposure are associated with changes in small and large blood vessels, nerves, kidneys and, as the osteoarthritis work above suggests, joint tissue 2. A single suboptimal value does not predict any of that.
The next step is a conversation, not a conclusion. A high result is worth discussing with a clinician alongside fasting glucose, hemoglobin A1c, insulin and albumin, and worth repeating to see whether it reflects a trend or a bad fortnight. Where symptoms are marked or the value is well outside the range, it is worth discussing with a clinician promptly. Structured screening and follow-up matter here, and research in hospitalized cardiac patients indicates that an intensive diabetes screening and management programme improved diagnosis and outcomes 7.
A low result can mean average glucose was genuinely low over the past few weeks, but it just as often reflects low serum protein or faster protein turnover, in which case the marker is underestimating glucose rather than reporting good control.
When the low value does track low glucose, people describe shakiness, sweating, irritability, hunger, light-headedness, difficulty concentrating or waking during the night. When it tracks low albumin instead, the reported experience is different, often swelling in the ankles or around the eyes, unusual fatigue, or symptoms of whatever is driving the protein loss.
Common contributors to a low value include low serum albumin from liver disease, nephrotic syndrome, protein-losing gut conditions, severe illness or inadequate protein intake, hyperthyroidism speeding protein turnover, pregnancy, and glucose-lowering therapy that has lowered average glucose substantially. Some assays are also reported to be sensitive to high-dose vitamin C and to haemolysed samples.
The long-term significance depends entirely on which explanation applies. If average glucose really is low, repeated hypoglycemia is worth prompt clinical attention, particularly in people using glucose-lowering medication. If albumin is low, the protein loss itself is the question worth answering, and the fructosamine value should not be read as reassurance about glucose control. Either way, pairing the result with an albumin measurement and a longer-window glycemic marker is what makes it interpretable.
Plenty can, and not all of it is glucose, so the sensible approach is to read the value in context rather than in isolation.
Testing conditions. Fasting is not required, which is one of the test's practical advantages. Hydration status at the draw, sample handling, haemolysis, high triglycerides and the specific assay platform can all shift the number. Comparing results across laboratories is unreliable; comparing a series from one laboratory is far more useful.
Protein status. Because the assay measures glycated serum protein, anything that moves albumin moves the result. That includes liver and kidney conditions, inflammation, severe illness and protein intake.
Medications. Several prescribed medicines can influence the value, directly or through protein turnover. This page gives no doses, schedules or administration steps for any prescription therapy. A licensed provider evaluates whether a given therapy is appropriate for a given person and makes those decisions.
Habits. Several randomized trials in people with type 2 diabetes or prediabetes have examined lifestyle inputs that move glycemic markers 8 10. A randomized controlled trial of exercise combined with a herbal tea in type 2 diabetes studied the effect of structured activity on glycemic outcomes 8. Research in older adults with obesity examined weight reduction with enhanced protein intake and its effect on inflammation biomarkers 9, a relevant combination given that protein intake also influences albumin. A six month double-blind randomized trial in postmenopausal women with prediabetes or untreated early diabetes examined soy protein and isoflavones for effects on glycemic control and insulin sensitivity 10. Sleep and circadian timing appear to matter as well, and a randomized controlled trial of light therapy in older adults with type 2 diabetes living in long-term care examined its effects on sleep and circadian rhythm 11. None of these findings is a promise about any individual's result.
Timing. Because the window is two to three weeks, changes made this week do not show up tomorrow. Retesting sooner than a few weeks after a meaningful change usually tells you very little.
FitScript does not currently test fructosamine in a panel. If you already have a result, from a clinician or another laboratory, you can upload your existing labs so that Atlas, FitScript's AI health advisor, reads it alongside your other glucose, insulin and protein markers rather than as an isolated number, and that interpretation becomes part of your FitScript.
The membership is built around 150+ biomarkers tested per year, which includes the longer-window glucose markers this test is usually compared against, so a fructosamine value from elsewhere has a context to sit in. Tracking matters more than any single reading, since the marker's whole advantage is showing movement over weeks.
Where results point toward a prescription option, a licensed provider reviews your labs, history and symptoms and decides whether anything is appropriate. The value of a repeat-and-review approach is supported by research showing that systematic screening and follow-up programmes improved diagnosis and outcomes in a hospital population 7.
On its own, a glycated protein value answers one narrow question. Read with these, it becomes far more useful.
Treat the number as one observation inside a trend. A value above the typical range suggests average glucose ran high over the past two to three weeks and is worth repeating with albumin and a longer-window marker. A value below it may mean low average glucose, or it may mean low protein, and the difference changes everything about how the result should be read.
You may also encounter this test outside human medicine. Veterinarians commonly use it in cats, where handling stress can raise a single blood glucose reading, and in dogs, because a multi-week average is harder to confound than a one-off sample. A veterinarian interprets those results, and the ranges used are species specific, not the human ones above.
This article is educational and is not medical advice. Discuss your results, and any therapy you are considering, with a clinician or licensed provider who can see your full history.
Both measure sugar attached to proteins, but they cover different windows. Hemoglobin A1c reflects roughly three months because red blood cells live that long, while fructosamine reflects about two to three weeks because serum proteins such as albumin turn over faster. Fructosamine is often used when red blood cell turnover is unusual or when a faster read on a recent change is wanted.
No. Because the test measures an average built up over weeks rather than the glucose in your blood at that moment, fasting is not required. Hydration and sample handling can still influence the result slightly, so follow whatever instructions the ordering laboratory gives you.
Most laboratories report a typical adult reference range of 190 to 270 µmol/L, and FitScript's optimal range is 190 to 228 µmol/L. Ranges vary by laboratory, assay, age and sex, and the optimal range is an optimization target rather than a diagnostic cut-off. Compare your result against the range printed on your own report.
Yes. The assay measures total glycated serum protein, so low albumin from liver disease, kidney protein loss, gut conditions, severe illness or low protein intake can pull the value down even when average glucose is unchanged. That is why an albumin measurement should usually be read alongside it, and some laboratories report an albumin-corrected value.
Repeat timing is set by the clinician who ordered it and depends on why it was ordered. Because the marker averages two to three weeks, retesting sooner than that after a change in diet, activity or therapy rarely shows anything meaningful. Tracking a series from the same laboratory is more informative than any single value.
Cats commonly develop stress hyperglycemia during a clinic visit, which makes a single blood glucose reading hard to interpret. A fructosamine test averages the preceding weeks, so it is less affected by handling stress and is widely used in cats to help assess and monitor diabetes. A veterinarian interprets the result using feline-specific ranges.
Yes, veterinarians use it in dogs too, for the same reason it is useful in people, a multi-week average is harder to confound than a one-off sample. The reference ranges used in dogs are species specific and differ from human ranges, so a canine result should only be interpreted by a veterinarian.
Red blood cell turnover and blood volume change during pregnancy, which can make hemoglobin A1c harder to interpret. A shorter-window glycated protein marker is sometimes used alongside other tests in that situation. Protein and albumin changes in pregnancy can also shift the value, so it is read in context by the clinician managing the pregnancy.
Anything that lowers average glucose over the following weeks tends to move the number, including dietary changes, regular activity, weight reduction and better sleep. Exercise, protein intake, soy isoflavones and circadian light exposure may help glycemic markers in type 2 diabetes or prediabetes, but none of them guarantees a result. Discuss your own result and any therapy with a clinician or licensed provider.